-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
More than 60,000 boxes of inferior drugs into the market, is the common drug Nofluoroxastar capsules, the new version of the Drug Administration Law implemented in that, whether it is pharmaceutical production enterprises or sales enterprises, the future punishment is more stringentrecently, Guizhou Drug Administration informed Guizhou Guangzheng Pharmaceutical Co., Ltdthe production of inferior drug Nofluoroxastar capsule informationaccording to the administrative penalty decision issued by the Guizhou Provincial Drug Administration, two batches of Novosacin capsules (lot number JAE0910, JAE0824) produced by Guizhou Guangzheng were tested and detected by zunyi City Food And Drug Inspection Institute and found that the degree of dissolving did not conform to the regulations2 batches of 792,000 boxes, has been recalled about 119,000, about 672,000 boxes have been soldthat means more than 60,000 boxes of bad drugs are still flowing through the marketthe degree of drug solubility, also known as the rate of solutation, refers to the speed and degree of drug dissolving from solid preparations such as tablets, capsules, granules, etcunder the prescribed solvents and conditions, and it is one of the required test items for drug quality controlAccording to the Health Times, Lu Yang, professor of pharmacy at Beijing University of Traditional Chinese Medicine, told reporters that the solubility of the Nofluorosa chemical in water is poor, whether the degree of drug solubility is qualified is the key to the capsule dosage typeIt is related to the clinical effect of drugs, which affects the safety of patientsdrugs thatdo not meet the standards of medicines are inferiorThis time, in accordance with the Drug Administration Law of the People's Republic of China, Guizhou Guangzheng, which produces and sells inferior drugs, confiscated inferior drugs, sold the proceeds and fined 0.5 times, totalling 231.7 million yuanmanufacturers respond: drugs suspected of being damped, has been eaten and nothingit is understood that before the announcement issued by the Guizhou Drug Administration, May 10, 2019, Guizhou Guangzheng Pharmaceuticals has been batch number JAE0910, JAE0824 of the Novosacstar capsules to launch a three-level recallthe unrecalled more than 60,000 boxes of non-fluorosacin capsules, consumers after the purchase of what to do?five times to this reporter called the drug company's quality regulator in the hope of finding an answer, but the phone has not been through Then the reporter to consumer rights, found responsible for the Novosax capsule this product sales and after-sales Su manager "s "third-level recalls do not involve consumer terminals, mainly for inventory and the recall of drugs in circulation channels Su said that all drugs will have a test report before the factory, the inspection will be certified before they will be sold These two batches of capsules were tested at the time is qualified, there is a non-conformity situation, suspected to be related to the market sales enterprises in the circulation, storage process is not standardized for consumers who have already bought or used, Su said, "It doesn't matter if you eat, the medicine is not a fake drug, it is not expired, there may be some moisture, not much impact." If still not assured, can be returned to the drug factory, the drug factory will refund the consumer related costs." experts suggest: stop taking, replace drugs
"bad medicine is not qualified drugs, taking will affect the efficacy, but also may have unpredictable risks." Deng Guiming, deputy director of the First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, told reporters that some of the bad medicine at home should not continue to be used, can be thrown away If a drug is found to be in the category of a bad medicine after purchase, it can be returned to the pharmacy or manufacturer where the drug was purchased reporter found that the price of Novosax capsules on the market ranged from 2.5 yuan to 10 yuan/box Guizhou Guang is selling the drug in the national hospital price of 2.48 yuan / box, drugstore price 3-5 yuan / box, the price is at the lowest level if you eat nothing, also recommend edatosed, if a problem occurs, should be timely medical treatment, related damage can find manufacturers compensation Deng Guiming reminded that if there is no quality problem at the time of purchase, just because of expiration or improper storage of their own quality problems, there is no reason to buy the drug store or manufacturers to return according to the Drug Administration Law, if the quality of drugs is damaged, the victim may request compensation from the drug market ingress license holder or the drug production enterprise, or the drug business enterprise or medical institution may seek compensation for the loss If a victim's request for compensation is received, the first responsibility system shall be implemented and the first payment shall be carried out; Su manager said that in view of this, the company in the future in the circulation and storage of drugs, will be added a moisture bag, increase drug stability drugstores to sell counterfeit drugs, the penalties are more severe
whether it is production enterprises or sales enterprises, the production and sale of counterfeit drugs, the future punishment will be more severe on the one hand, the production and marketing of counterfeit drugs in production and marketing enterprises are more severe punishment according to the New Drug Administration Law, the amount of fines for unlicensed production and operation, production and sale of counterfeit drugs and other illegal acts, the amount of fines from the value of goods from two to five times to 15 times to 30 times, the value of the goods less than 100,000 yuan in 100,000 yuan Fines for the production and sale of inferior drugs have also increased from double to triple the value of the goods to ten to twenty times on the other hand, for retail pharmacies, the sale of counterfeit drugs will also face more severe penalties than in the past, the sale of counterfeit drugs by licensed pharmacists will likely be held accountable although the implementation of the new version of the Drug Administration Law on December 1st is still some time away, but some areas have revised the administrative penalty discretion benchmark, and increased supervision of pharmaceutical production enterprises and sales enterprises take Shandong Province as an example, on October 31, the Shandong Provincial Drug Administration publicly solicited opinions on the "Shandong Province Drug Administrative Penalty Discretionary Benchmark (Drug) (Draft for Comments)" and the types of penalties for the production, sale and use of counterfeit drugs were: confiscation of illegal income, confiscation of illegal property; suspected of producing, selling or using inferior drugs, the penalties shall be as follows: confiscation of illegal income, confiscation of illegal property; fine; ordering the suspension of production and suspension; revocation of approval documents, licenses and practising certificates; lifetime prohibition of employment; and confiscation of income earned during the period of illegal acts the same day, the Jiangsu Provincial Drug Administration made a public announcement on the criminal punishment of practicing pharmacists According to the judgment of the High Post City People's Court, two practicing pharmacists were subject to criminal penalties, the statement said.